THE FUTURE OF VACCINES, ADDRESSING GLOBAL HUMAN HEALTH NEEDS I Future Investment Initiative 6th Edition
NOW: Vaccine inequity has kept poor nations even poorer. Less than 20 countries in the world have the technological capacity to produce vaccines. Trade policies, such as national export curbs, have delayed the flow of vaccines to needy regions. Unnecessary stockpiles also continue to be a concern, with the G7 and EU combined predicted to have a surplus of 1.39 billion vaccines as of the end of Q1 2022. NEXT: How can investors support vaccine-production capacity in emerging and developing economies? Which new policy choices would help ease international vaccine trade? How can governments be persuaded to redistribute unnecessary vaccine stockpiles?
SPEAKERS
● Mei Mei Hu, CEO, Vaxxinity, Inc.
● Sudarshan Jain, Secretary General, Indian Pharmaceutical Alliance
MODERATOR
● Peter H. Diamandis, MD, Executive Chairman, XPRIZE & Fountain Life, & Future Investment Initiative Institute Board Member
11